At 55, John Walsh should be dead, but his power of one exponentially continues attacking one of the most lethal lung diseases. Walsh said he's one out of every 2,750 Americans born with ...
The FDA has approved Prolastin-C (alpha1-proteinase inhibitor [human], from Talecris Biotherapeutics), a more concentrated formulation of Prolastin, for the treatment of alpha1-antitrypsin (AAT) ...
James M Stocks; Mark L Brantly; Laurene Wang-Smith; Michael A Campos; Kenneth R Chapman; Friedrich Kueppers; Robert A Sandhaus; Charlie Strange; Gerard Turino ...
Grifols’ advances in the science of alpha-1 underscore its robust innovation pipeline and commitment to testing and treatment for the alpha-1 community BARCELONA, Spain, July 13, 2023 (GLOBE NEWSWIRE) ...
LONDON, GREATER LONDON, UNITED KINGDOM, January 22, 2025 /EINPresswire / -- Is the Prolastin and Prolastin C Market Set to Witness Substantial Growth? With the Global Prolastin and Prolastin C market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results